Literature DB >> 9722518

Activation of the Janus kinase/signal transducer and activator of transcription pathway by osmotic shock.

P Gatsios1, L Terstegen, F Schliess, D Häussinger, I M Kerr, P C Heinrich, L Graeve.   

Abstract

Numerous cytokines, growth, and differentiation factors elicit their intracellular responses via Janus tyrosine kinases (Jaks) and transcription factors of the STAT (signal transducer and activator of transcription) family. Additionally, environmental stress (UV light, heat, aniso-osmolarity, and radicals) has recently been shown to activate intracellular signaling cascades such as the stress-activated protein kinases and nuclear factor-kappaB. In this study, we demonstrate that in different cell lines a particular stress, namely hyperosmolarity, results in tyrosine phosphorylation of the Janus kinases Jak1, Jak2, and Tyk2 and in the activation of STAT1 and/or STAT3. Both transcription factors are phosphorylated at a specific tyrosine residue and translocation to the nucleus was demonstrated by the use of a STAT3/green fluorescent protein fusion protein. A prominent role for Jak1 in the activation of STATs by hypertonicity was demonstrated by the use of Jak-deficient cell lines. Stress-activated STAT1 and STAT3 transactivate a reporter gene containing the acute-phase response element of the rat alpha2-macroglobulin promoter. Experiments using a diffusible solute suggest that not the increase in intracellular osmolarity but the resultant cell shrinkage is the trigger for Jak/STAT activation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9722518     DOI: 10.1074/jbc.273.36.22962

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Downregulation of the creatine transporter SLC6A8 by JAK2.

Authors:  Manzar Shojaiefard; Zohreh Hosseinzadeh; Shefalee K Bhavsar; Florian Lang
Journal:  J Membr Biol       Date:  2012-03-11       Impact factor: 1.843

2.  Evidence that DIF-1 and hyper-osmotic stress activate a Dictyostelium STAT by inhibiting a specific protein tyrosine phosphatase.

Authors:  Tsuyoshi Araki; Judith Langenick; Marianne Gamper; Richard A Firtel; Jeffrey G Williams
Journal:  Development       Date:  2008-02-27       Impact factor: 6.868

3.  Down-regulation of the epithelial Na⁺ channel ENaC by Janus kinase 2.

Authors:  Zohreh Hosseinzadeh; Dong Luo; Mentor Sopjani; Shefalee K Bhavsar; Florian Lang
Journal:  J Membr Biol       Date:  2014-02-23       Impact factor: 1.843

4.  Downregulation of KCNQ4 by Janus kinase 2.

Authors:  Zohreh Hosseinzadeh; Mentor Sopjani; Tatsiana Pakladok; Shefalee K Bhavsar; Florian Lang
Journal:  J Membr Biol       Date:  2013-03-30       Impact factor: 1.843

5.  Tonicity-responsive enhancer binding protein, a rel-like protein that stimulates transcription in response to hypertonicity.

Authors:  H Miyakawa; S K Woo; S C Dahl; J S Handler; H M Kwon
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

6.  Dual regulation of a Dictyostelium STAT by cGMP and Ca2+ signalling.

Authors:  Tsuyoshi Araki; Wouter N van Egmond; Peter J M van Haastert; Jeffrey G Williams
Journal:  J Cell Sci       Date:  2010-02-16       Impact factor: 5.285

7.  A VEGF/JAK2/STAT5 axis may partially mediate endothelial cell tolerance to hypoxia.

Authors:  Andrew C Dudley; David Thomas; James Best; Alicia Jenkins
Journal:  Biochem J       Date:  2005-09-01       Impact factor: 3.857

8.  Mesangial cell gelatinase A synthesis is attenuated by oscillating hyperbaric pressure.

Authors:  Abdelaziz En-Nia; Julia Reisdorff; Ioannis Stefanidis; Juergen Floege; Peter C Heinrich; Peter R Mertens
Journal:  Biochem J       Date:  2002-03-15       Impact factor: 3.857

Review 9.  JAK redux: a second look at the regulation and role of JAKs in the heart.

Authors:  Mazen Kurdi; George W Booz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-28       Impact factor: 4.733

Review 10.  Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution.

Authors:  Uddalak Bharadwaj; Moses M Kasembeli; Prema Robinson; David J Tweardy
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.